Johnson & Johnson JNJ NYSE

Johnson & Johnson (JNJ) reported moderate year-over-year revenue growth of +6% through 2025-12 (TTM revenue vs prior-year TTM). Net income showed exceptional earnings expansion of +90.6% YoY, reaching $5.1B in the latest quarter. The net profit margin is 20.8%, which is high. The company has maintained profitability in all 4 quarters. The gross margin is 72.6% (high), up 3.5pp vs the prior year. With a $579B market cap, MOAT composite score of 100/100 (strong competitive position).

Criteria proven by this page:

• GROWTH (83/100, Pass) — proving strong growth momentum
• PAST (100/100, Pass) — proving consistent earnings. Looking at the full 53-year annual history, the company was profitable in 53 of 53 years — a perfect long-term track record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (100/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 73/100 with 4/7 criteria passed.